4//SEC Filing
Cavalier Jason 4
Accession 0000899243-23-003513
CIK 0001327273other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:11 PM ET
Size
5.7 KB
Accession
0000899243-23-003513
Insider Transaction Report
Form 4
Cavalier Jason
Chief Financial Officer
Transactions
- Award
Stock Option
2023-01-31+140,000→ 140,000 totalExercise: $2.85Exp: 2033-01-30→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 31, 2023.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001883290
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:11 PM ET
- Size
- 5.7 KB